Concepedia

Lukas F. Mager

LF

9

Publications

1.7K

Citations

9

H-Index

2011

Active since

Affiliations

University of Bern(Current)

University of Calgary

University Hospital of Zurich

SIB Swiss Institute of Bioinformatics

University Hospital of Bern

Lukas F. Mager is an author at University of Bern specializing in cancer research, prebiotics, and host-microbe interactions.

ORCID

Top concepts

Publications per year

2011–2022

9

Publications

9

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

Lukas F. Mager, Regula Burkhard, Nicola Pett et al. · Science · 2020 · 1.2K citations

The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer

Eva Pastille, Marie-Hélène Wasmer, Alexandra Adamczyk et al. · Mucosal Immunology · 2019 · 141 citations · Full text

The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice

Kirsten D. Mertz, Lukas F. Mager, Marie-Hélène Wasmer et al. · OncoImmunology · 2015 · 92 citations · Full text

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms

Lukas F. Mager, Carsten Riether, Christian M. Schürch et al. · Journal of Clinical Investigation · 2015 · 90 citations · Full text

TREM-1 promotes intestinal tumorigenesis

Leslie Saurer, Daniel Zysset, Silvia Rihs et al. · Scientific Reports · 2017 · 49 citations · Full text

Rows per page

1–5 of 9